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ABSTRACT
Objective: This review focused on Malaysian medicinal plants that have been evaluated and pose potentials to treat breast cancer.
Methods: Google Scholar, Web of Science, PubMed, Scopus, Biomed, ResearchGate, academia.edu, IEEE Xplore, ScienceDirect, and Ingenta databases 
were searched for this review and studies reported between January 1st, 2010 and June 30th, 2016.
Results: A total of 105 plants species representing 54 different families and 79 genera were reviewed. 97% of the plants were tested using MCF-7 and 
MDA-231 breast cancer cell lines and exhibited most significant in vitro anticancer activity, and 3% were tested using another type of breast cancer cell 
lines. Most of the bioactive compounds of the medicinal plants that exhibited good activity (IC50 values <120 µg/mL) are a group of phenols, alkaloids, 
flavonoids, terpenoids, and saponins. Induction of apoptosis was found to be the significant cell death pathway.
Conclusion: This article reviews the available literature concerning research on anti-breast cancer plants. Furthermore, identification and 
characterization of active components and toxicology evaluation also need to be studied in details and also point out their clinical trials.
Keywords: Breast cancer, Medicinal plants, Bioactive components, Anticancer mechanism.
INTRODUCTION
Cancer
Cancer is a group of diseases characterized by abnormal cell growth 
with the potential to affect to other parts of the body. Cancer is a 
condition that is related to an enormous cluster of diseases that disturb 
every region of the physique [1]. The World Health Organization (WHO) 
categorized cancer among the non-contagious disease which accounts 
for 63% of deaths globally [2]. Cancer is an intricate disease condition 
affecting millions of people all over the world [3].
Cancer epidemiology
Cancer is one of the principal reasons for fatality rate in the world, with 
roughly 14 million different events and also 8.2 million cancer-linked 
deaths in 2012 [4,5]. Death of individuals with cancer is increasing 
rapidly. The WHO reported that cancer accounted for 13% of world 
death that is about 7.6 million in 2005, and this percentage is expected 
to increase every year [6]. The number of new cases is likely to increase 
by 70% in the next two decades [2,7].
Breast cancer
Breast cancer is the most common cancer of women in Malaysia, with 
a prevalence of 86.2 per 100,000 women in 1996 [8]. Breast cancer 
comprised 30.4% of all female cancers in Malaysia, and this was higher 
compared to previous reports in Sabah with 18%, Kuala Lumpur 
(10.7–13.8%), and Singapore with 13% [9].
The WHO figured that, without abrupt action, the number of mortality 
caused by cancer would rise approximately 80% by 2030 with most 
occurring in low- and middle-income countries [10]. Siegel et al. [7] 
reported that 21.7 million cancer cases are expected to be diagnosed 
in 2030. In Malaysia, the second most communal source of death is 
cancer after heart-related diseases, and the dominant cancers are lung, 
breast, cervix, and leukemia [11]. It was estimated that yearly rate of 
cancer in Malaysia is 30,000. In 1998, the population of Malaysia was 
21.4 million, and the number of cancer is projected to grow in aged 
population by 2020 [12].
Cancer chemotherapy
Cancer chemotherapy represents an option for patients with breast 
cancer when an indication for chemotherapy is given to weaken and 
destroy cancer cells in the body, including cells at the original cancer 
site and any cancer cells that may have spread to another part of 
the body [13]. Breast chemoprevention can be defined as “the use 
of pharmacologic or natural agents that inhibit the development 
of invasive breast cancer either by blocking the DNA damage that 
initiates carcinogenesis or by arresting or reversing the progression of 
pre-malignant cells in which such damage has already occurred [14]. 
Unfortunately, this treatment has not been fortunate enough to impart 
significant improvement in the morbidity or mortality of breast 
cancer due to the severe side effects; this cancer is highly resistant to 
chemotherapy as no effective treatment exists for advanced disease 
conditions [15]. The most common drugs used in the treatment of breast 
cancer chemotherapy are tamoxifen [16], raloxifene [17], aromatase 
inhibitors [18], polymerase inhibitors [19], and trastuzumab [20]. Other 
drugs include anthracyclines, taxol,  cyclophosphamide, carboplatin, 
docetaxel, paclitaxel, cisplatin, carboplatin, vinorelbine, capecitabine, 
doxil, gemcitabine, mitoxantrone, and ixabepilone.
Cancer cell resistance to chemotherapy is still a heavy burden that 
impairs treatment of cancer patients. Both intrinsic and acquired 
resistance results from the numerous genetic and epigenetic 
occur in cancer cells. Most of the hallmarks of cancer cells provide 
general mechanisms to sustain stresses such as the ones induced by 
chemotherapeutic drugs. Moreover, specific changes in the target 
bring resistance to specific drugs such as modification in nucleotide 
synthesis enzymes on antimetabolite exposure, in microtubule 
composition on spindle poison treatment, in topoisomerase activity 
on topoisomerase inhibitor incubation, or intracellular signaling 
pathways when targeting tyrosine kinase receptors [21]. The first 
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cause of therapeutic failure results from genetic alterations existing 
before treatment; this is the primary or intrinsic resistance. The second 
one is induced by drug treatment and is called secondary or acquired 
resistance. Both are due to mutations in the genome of cancer cells and 
to epigenetic changes. Unfortunately, resistance appears not only to 
conventional chemotherapy but also to targeted therapies, the so-called 
smart drugs to standard chemotherapy such as kinase inhibitors and 
tamoxifen that binds to the estrogen receptor (ER) [21,22]. However, 
due to the shortcomings of modern treatment, nowadays, finding active 
complexes of the plant has been accelerated using modern techniques, 
and this has resulted in plants recycle. Thus, drugs that are produced 
from herbal plants are usually specialized in treating chronic disease 
like cancer [23]. Many plants with cancer-fighting properties were 
identified which have a high attraction to a biological target and their 
strength to inhibit the cancer metastasis is studied widely. Active 
components from some medicinal plants are yet to be identified, but 
crude extracts display cytotoxic action against most of the human 
cancer cell lines. Knowledge of these indigenous anticancer plants 
forms the platform for new, safe, and effective drug development [24].
Although the use of plants for cancer remedy has been traced for the 
past four decades with many of articles, but so far in the past 10 years, 
there were only 2 major reviews and other few mini-reviews that 
reviewed the medicinal plants use in the treatment of breast cancer 
in another part of the world. In 2012, Nagaprashanthi et al. [25] 
reviewed 56 important ethnomedicinal plants (indigenous system of 
medicine) evidenced for breast cancer by the scientific study [25]. They 
published a full-length paper on ethnobotanical survey and digitization 
of medicinal and aromatic plant-based foods for effective breast cancer 
treatment, by randomly administering semi-structured questionnaires 
to 70 physicians and interviewed 500 complementary and alternative 
medicine practitioners, and 78 plants were reviewed [26]. Lakshmi [27] 
reviewed and compiled data of anticancer activity of three traditional 
herbs, namely, Zingiber officinale, Semecarpus anacardium, and Fagonia 
cretica. Another review by Islam et al., [28] published their review of 
herbal medicinal plant in the treatment of breast cancer and relationship 
between medicinal herbs, and some tumour suppressor molecules 
focused on gene expression and posttranslational modifications, and 
some tumor suppressor molecules focused on gene expression and 
post-translational modifications [28]. Dembitsky [29] published a 
review paper on anti-breast cancer agents derived from plants analyzing 
anti-breast cancer potencies of quite a few extracts from different 
plant sources and compared their anti-proliferative efficiency of crude 
extracts with actions of their purified ingredients [29]. A review by 
Elgadir et al. [30] highlighted ten anticancer plants particularly used 
for breast cancer and outlined some evidence for the success of using 
natural products as anticancer with selected in vitro and in vivo studies 
on anticancer plants with their anticancer compounds and their effects 
as anticancer. Jaikumar and Jasmine [31] considered 58 medicinal 
plants from various families that have inhibited cell growth at different 
IC50 values against MCF-7 [31]. Another editorial titled “natural cures 
for breast cancer treatment,” focused on the biochemical properties of 
different types of plants that retain the immune stimulating and anti-
tumour properties [32]. However, of the reviews above, only one review 
is from Malaysia and only ten medicinal plants were reviewed, that is, 
what motivate the writers to look back due to huge individual articles 
on breast cancer medicinal plants but yet review articles are lacking.
The general mechanism of cancer therapy
The general mechanism of cancer therapy includes antiproliferation of 
cells directly by enhancing killer cell activity naturally and promoting 
macrophage phagocytosis, stimulating apoptotic cancer cells through 
rising the output of immunoglobulin, nterleukin2, blood serum 
complement and interferon, necrosis enforcement of the tumor, 
preventing translocation of tumor, and disseminate by obstruction the 
tumor tissue source of blood, improving the quantity of platelets and 
leukocytes through motivating the hemopoietic role, encouraging the 
opposite transformation from tumor cells into regular cells, helping 
metabolism and averting carcinogenesis of regular cells and lastly 
appetite stimulation, relieving pain, improvement in sleeping quality, 
and hence benefiting patients’ well-being [33]. While the mechanism 
of breast cancer therapy is likely to be in connection with molecular 
mechanisms of antiestrogen therapy and endocrine resistance to 
treatment all stages of breast cancer. Recent studies shows that 
tamoxifen and the new pure antiestrogens appear to have different 
mechanisms of action: Tamoxifen and related compounds cause a 
change in the folding of the steroid binding domain that prevents gene 
activation, whereas the pure antiestrogens cause a reduced interaction 
at response elements (RE) and cause a rapid loss of receptor complexes. 
Tamoxifen treatment produces the changes in the cellular and 
circulating levels of growth factors that could influence both receptor-
negative or receptor-positive tumor growth and the metastatic potential 
of a tumor [34,35].
Mechanisms of ER action in breast cancer
Genomic activity of estrogen bound ER, crosstalk with growth factor 
receptor tyrosine kinases such as EGFR, HER2, and IGF1- R) and with 
additional signaling and coactivator molecules activates multiple 
downstream kinase pathways (e.g. PI3K/AKT-mTOR and Ras/p42/44 
MAPK) which in turn phosphorylate various transcription factors 
(TFs) and coregulators, including components of the ER pathway that 
enhances gene expression on EREs and other RE. The non-nuclear/
non-genomic activity, which can also be activated by tamoxifen, is 
enhanced in the presence of overexpression and hyperactivation of 
RTKs and can contribute to endocrine therapy resistance. Overall, the 
nuclear/genomic and non-nuclear/non-genomic ER activities work 
in concert to provide breast tumor cells with proliferation, survival, 
and invasion stimuli. Signaling from the microenvironment activates 
stress-related pathways, and members of the integrin family interact 
with downstream kinase pathways that can further modulate of the 
transcriptional machinery including ER [36].
METHODS
Google Scholar, Web of Science, PubMed, Scopus, BioMed, ResearchGate, 
academia.edu, IEEE Xplore, ScienceDirect, and Ingenta databases were 
used for this review and paper selected between January 2010 and June 
2016 (5 years). The search terms used are “cancer” and “breast cancer,” 
“anticancer plants,” “Medicinal Plants,” “traditional medicine,” “anti-
breast cancer plants,” or “herbs” without narrowing or limiting search. 
Reports with available abstracts, methods, discussion, and conclusion 
were reviewed.
RESULTS AND DISCUSSION
Malaysia is rich in biodiversity and has hundreds of flora that are 
used in traditional medicine and many more used in general folklore 
medicine. The plants were shown to produce additional information 
such as their phytochemical constituents (bioactive compounds), 
pharmacological properties, and their mechanism of action. Majority of 
the plants screened for anticancer properties have been used in either 
traditional medicine or as food. The use of traditional medicine has 
expanded, and health supplement consisting of different types of herbal 
medicines has become very popular in Malaysia in the recent years. The 
widely consumed plants as food additive and medicine are believed to 
possess anticancer potentials [37].
Medicinal plants have played an important role in the treatment of 
breast cancer. In this review, 100 anti-breast cancer plants belonging 
to 54 families and 79 genera have been presented in scientific, common 
local, and family names. Part and solvent used, active component(s) 
identified, breast cancer cell line and mechanism of action were also 
presented (Table 1). From Table 1, 22 species representing 22% of the 
total plants demonstrates strong anticancer activities such as Annona 
squamosa with IC50 value of 10 μg/mL, Bauhinia purpurea with IC50 
value of 9 μg/mL for MCF-7 and IC50 value of 17 μg/mL for MDA-231, 
Calotropis gigantea with IC50 value of 1.3 μg/mL for MCF-7 and IC50 
value of 3.3 μg/mL for MDA-231, Piper nigrum with IC50 value of 13 μg/
mL, Casearia capitellata with IC50 value of 2 μg/mL in MCF-7, Hedyotis 
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corymbosa with IC50 value of 6.51 μg/mL in MCF-7 and IC50 value of 
2.75 μg/mL in MDA-231, Nephelium lappaceum with 100% inhibition at 
IC50 value of 8 μg/mL, Psidium guajava in MDA showed the cytotoxicity 
of IC50 of 4.23 µg/mL, Peperomia pellucida with IC50 value of 10.4 μg/mL, 
Phaleria macrocarpa with IC50 value of 25.5–40.8 μg/mL, Curcuma 
xanthorrhiza IC50 value of 1.71±0.1 μg/mL, Mangifera pajang with IC50 
value of 23 μg/mL in MCF-7 and IC50 value of 30.5 μg/mL in MDA-231 
and Phyllanthus pulcher with IC50 value of 18.9±0.7 μg/mL while most 
of the lowest activities were found in Etlingera elatior with IC50 value 
of 173.1 μg/mL in MCF-7 and IC50 value of 196.2 μg/mL in MDA-231, 
Albizia zygia with IC50 value of 83.16 μg/mL, Litsea garciae with IC50 
value of 73 μg/mL, Phyla nodiflora with IC50 value of 90–120 μg/mL, 
Moringa oleifera with IC50 value of 87.13 μg/mL, Artocarpus altilis 
exhibiting strong free radical scavenger towards DPPH with IC50 value 
of 2 μg/mL, and Amaranthus gangeticus with IC50 value of 98.8 μg/mL, 
Dendrophthoe pentandra with IC50 value of 107 μg/mL in MCF-7 and IC50 
value of 112 μg/mL in MDA-231, and Trigonella foenum and Theobroma 
cacao with IC50 value of 41.4 μg/mL.
Some of the bioactive compounds that were isolated and found to be 
responsible for the anticancer activities from these medicinal plants 
that exhibited good activity are pyranocycloartobiloxanthone A (PA), 
dihydro-artoindonesianin C, and pyranocycloartobiloxanthone B 
isolated from Artocarpus obtusus and shows strong cytotoxic activity 
against MCF-7 and MDA-MB-231 with IC50 values of 5.0μg/mL in) at 
30μg/mL concentartion and IC50 value of 2μg/ in Artocarpus altilis. 
Dentatin also isolated from Clausenaex cavata arrest MCF-7 at G0/
G1 phase and ROS was significantly elevated. Moreover, dentanin 
(DTN) significantly blocked the induced translocation of NF-kB from 
the cytoplasm to the nucleus, silver nanoparticles (AgNPs) isolated 
from Alternanthera tenella, and Coriandrum sativum inhibited cell 
migration dose-dependently after 24 h of treatment. The IC50 value of 
the AgNPs was calculated to be 42.5 Lg/mL and inhibits the MCF-7 by 
the upregulation of the p53 tumor suppressor gene expression and 
the subsequent rise in expressions of pro-apoptotic proteins such as 
caspase-3, Bax, and caspase-9, respectively. Benzoquinonoid fraction 
(BQ) isolated from hexane extract of Ardisia crispa inhibited both COX-
1 and COX-2. Amygdalin isolated from Amaranthus lividus activated 
a pro-apoptotic signalling molecule p38 mitogen-activated protein 
kinases (p38 MAPK) in Hs578T cells and induces apoptosis and also 
inhibits adhesion of breast cancer cells. Andrographolide isolated from 
Andrographis paniculata Induced apoptosis in MDA-MB-231, anti-
proliferative activity by mitochondria dependent caspase mediated 
pathway and cell cycle arrest at G2 and M. Damnacanthal isolated 
from Morinda citrifolia induced apoptosis, and expression of  caspase 
7 activation of p21, leading to the tran¬scription of p53 and the Bax 
gene. Diallyltrisulfide isolated from Allium sativum stimulates the 
lymphocytes and macrophages that  kills cancerous cells and interferes 
with tumor cells metabolism. Vernodalin isolated from Centratherum 
anthelminticum seeds inhibits cell growth of MCF-7 and MDA-MB-231 
by induction of cell cycle arrest and apoptosis, increased of reactive 
oxygen species (ROS) production coupled with a downregulation of anti-
apoptotic molecules (Bcl-2 and Bcl-xL) led to reduction of mitochondrial 
membrane potential and the release of cytochrome c from mitochondria 
to cytosol which triggered activation of caspase cascade, PARP cleavage, 
DNA damage and eventually cell death. Iaxanthone, coumarin and 
iacoumarin isolated from Lawsonia inermis Inhibites proliferation of 
tumor cell at IC50 value  of  24.85μg/ml. 1’S-1’-Acetoxychavicol acetate 
(ACA) isolated from Alpinia conchigera induced cell cycle arrest at G0/G1 
phase with IC50 values 34.0 µM to 48.0 µM. Xanthorrhizol isolated from 
the rhizome of Curcuma xanthorrhiza inhibites proliferation of MCF-7 
with an EC50 value of 1.71μg/ml and also revealed down-regulation of 
the anti-apoptotic bcl-2 protein expression. longilactone isolated from 
Eurycoma longifolia exerts a strong cytotoxic activity on MCF-7 with IC50 
of 0.53 ± 0.19 µg/ml, also induced apoptosis as evidenced by nuclear 
condensation, fragmentation and margination, and also shows activation 
of caspase-7,-8 and poly (ADP-ribose) polymerase. Eurycomanol isolated 
from Eurycoma longifolia shows cytotoxicity at  IC50 15.23±0.66μg/ml 
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ml.  Alkenylresorcinols,  labisiaquinone A and labisiaquinone isolated 
from leaves of Labisia pumila exhibited strongest cytotoxic activity 
against MCF-7 cell line at IC50 values ˂10µm.
These plants contain other chemicals that are not isolated but 
rather suspected to be the principal agent for the anticancer 
activities these are apigenin, apigenin glycosides, luteolin, luteolin-7 
glucosides, p-coumarin, lupeol, lectins, naringin, nodifloretin, β 
silosterol, mangiferonic acid, pellitorine, kaempferol [38], curcumin, 
curcuminoids, a-turmerone, [33,37,39,40], quercetin [41,42], 
catechin, rutin [43], xanthorrhizol [40], mangiferin [44], ferric 
thiocyanate, thiobarbituric acid, isoquercetin, astragalin [45], 
damnacanthal [46], naphthoquinones [47], triterpenoids, flavonoids, 
gallic acid, gingerol [48] anonaine, isolaureline, annonamine [49], 
xanthones [50], flavonoids, stigmasterol, carotenoids, and ascorbic 
acid [51], among which many are reported for their cytotoxicity 
and chemopreventive activity against breast cancer cell that are 
promising anticancer agents and has been adapted for alternative 
cancer therapies. Many studied plants were shown to possess variable 
chemical compounds that possess a tumor suppressive activities 
and associated with potent anticancer responses, [37,40,44,51-53]. 
These compounds can be considered as promising candidates for 
the development of novel and effective pharmaceutical agents. 
Studies have shown that the chances for a plant to be bioactive are 
significantly higher when plants’ selection is done by ethnomedicinal 
approach as compared to random plant selection. It is anticipated that 
the present review can be used to validate ethnomedicinal practices 
and bioactivities of these plants.
Anticancer mechanism
1. Inhibition of lipid peroxidation as exhibited by Garcinia mongostana [54], 
Alstonia scholaris [55, 56] and Annona muricata [49, 57, 58].
2. Scavenging reactive oxygen species (ROS) as shown by Abrus 
agglutinin and Allium sativum [59, 60] and normalize n (AFP) levels 
in Allium sativum [33]. 
3. Inhibiting proliferation via the activation of caspase-3 and caspase-9, 
up-regulation of the ratio of bax/bcl-2 protein expression in Ardisia 
brevicaulis [61] Artocarpus obtusus [50, 62] Ardisia brecaulis [63], 
Carica papaya [64] Catharanthus roseus [118-119], Costus 
speciosus [121-122], Cucuma zedoaria [65], Dysoxylum cauliforum [66], 
Goniosthalamus macrophyllus [137-138], Gynura procumbens [139], 
Lawsonia inermis [56,146-147], Leea indica [148-149], Nepthelium 
lappaceum [56,156] Pandanus amarylfolius [41], Phyla nodiflora [67], 
Physalis minima [52, 78], Rhodiola rosea [68], Vernonia amygdalina 
[65] and Schima wallichi [38]. 
4. Induced mitochondrial and nuclear DNA damage like in Curcuma 
longa [33, 37]. 
5. Organelle organisation alteration, cellular plan and differentiation 
degree of cellular metabolism in Azadirachta indica [65]. 
6. Increase histone acetylation like in Allium cepa [60]. 
7. Declined in polymorphonuclear leukocyte infiltration and migration, 
reduced primary antibody synthesis and nearly inhibited the classical 
complement pathway like in Boswellia serrate [69, 70]. 
8. Cell morphological changes such as cytoplasmic shrinkage, 
condensation of nucleus and formation of membrane-bound vesicles 
in Abrus precatorius [59, 71] and Scurrula ferruginea [88, 166]. 
9. Expression levels of apoptosis-related genes (caspase-3 and 
caspase-9) Tinospora crispa [72], Andrographis panniculata  [67, 
101-102], Brassica oleraceae [63, 80, 111], Curcuma xanthorrhiza 
[73], Eucheuma cottonii [66].
Anticancer drugs destroy cancer cells by stopping growth or 
multiplication at some point in their life cycle. This paper has shown 
that the cytotoxicity of plants that downregulate the anti-apopototic 
genes such as Bax/Bcl2 (apoptosis inducing genes) that promote 
cell death, like in Artocarpus obtusus [50], rise in Bax/Bcl2 ratio to 
induce apoptotic pathway like in Dillena suffruticosa [74] also in Z. 
offinalis [48], Juglans regia [47], L. pumila [75] and T. foenum [76] and 
on the other hand, the use of pro-apopotic genes like caspases, 3, 7, 8 
and 9, and P53 has make a clear expression in in Artocarpus obtusus 
[50], C. sativum [95], G. macrophyllus [91], Persea declinata [80], 
P. minima [96], Sandoricum koetjape [89], T. foenum [94], S. 
wallichii [38], and Brassica oleracea [97]. Apoptosis and cell 
proliferation were the major biological pathway in cell death, and 
plant with highest apoptosis were A. sativum [33,60], C. sativum [98], 
Anisochilus carnosus, P. minima [52,96], Sandoricum koetjape [89], 
E. cottonii [43], C. xanthorrhiza [40], Nigella sativa [99], R. rosea [94], 
Sanchezia speciosa [100], and Ipomoea quamoclit [101], and those 
with least apoptosis were Phyla nodiflora [102], Brassica olorecea [97], 
Murraya koenigii [42], and Hydnophytum formicarum [103] while 
those plant that shows apoptosis with morphological changes includes 
E. longifolia [85], S. ferruginea [104], Syzygium aromaticum [63], 
C. longa [33,37], A. precatorius [59], and C. anthelminticum [105], 
and in cell cycle arrest, C. sativum, A. paniculata, and M. pajang arrest 
was made at G2/M [81,98,106,107], respectively, while arrest at 
S-phase was seen in Alpinia officinarum [108], sub-G1/S in Vernonia 
amygdalina [109], and reduction in G0/G1 phase with earlier increase 
in S and G2/M was observed in A. conchigera [110] and Muntingia 
calabura [111]. Finally, on the cell line used, almost all the plants were 
used against either MCF-7 or MDA-MB-231 or both.
Although the clinical trials showed that herbs were helpful against 
cancer, these outcomes require further confirmation with rigorously 
controlled trials, and many clinical trials focusing on the anticancer 
effects of herbal formulas have been conducted. Although many of 
them demonstrated that medicinal plants are helpful against cancer, 
especially useful in improving survival and quality of life in patients 
suffering from advanced cancer, the lack of controls and reporting bias 
have been severe flaws [33].
The information presented in this review aim at providing a general 
outline or descriptions of what type of mechanisms do plant extracts 
to inhibit cancer and also deliver therapeutic prove for some of the 
conventionally utilized anticancer plants. The pharmacological report 
advocates that these traditional practices are connected to the presence 
of dynamic compounds with anticancer potentials. Dissimilar plants 
have been found fighting against diverse cell lines of cancer even though 
this review only targets BC, pure chemical constituents have likewise 
been separated from these plants and established very active, still few 
numbers of pharmacological, phytochemical, and ethnomedicinal, 
examinations have been fully recognized on majority of these plants. 
Evidently, it is the time to lay more emphasis on scientific investigations 
on medicinal plants.
Anticancer drug suffers from generally inadequate efficacy and number 
of serious adverse effects in human health. These plants are commonly 
used in the conventional system of medicines in breast cancer remedies. 
Several reported works conclude that medicinal plants possess 
anticancer activities by the virtue of their active compounds, and in vivo 
and in vitro induced cancers are proved with scientific principles to 
ameliorate the cancers with use of these plant extracts. Introduction of 
apoptosis in cells in vitro can be done through different patterns. The 
typical systems are the disclosure of thymocytes to glucocorticoids. 
Other practices consist of DNA damage either by irradiation, exposure 
to drugs that prevent trypsin, topoisomerase, withdrawal of advance 
factors from growth media, cell cycle perturbation, exposure to 
inhibitors/activators of kinases or phosphatases, interloping with Ca2+ 
homeostasis, over the appearance of p53 adherents of Ced-3/ICE and 
so on.
CONCLUSION
Throughout the world, especially developing and under-developing 
countries, plants have been exploited as medicine to meet primary 
healthcare needs. There has been a great switchover in the universal 
trend of medicine selection from synthetic to herbal medicine, which 
indicates “Return to Nature.” Medicinal plants have been best known for 
millennial and are highly important all over the world as a rich source of 
therapeutic agents. It is estimated that vast majority of the population 
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relies on medicinal plants for therapy against several diseases or 
disorders [174,175].
A large number of novel anticancer drugs have been discovered from 
natural products in the past, and new ones are continually being 
developed; many plant species are still used by herbalists and traditional 
practitioner healers in Malaysia for treating breast cancer, considering 
the number of new cases in breast cancer and rising epidemiology in 
Malaysia. This review reports the investigations of many researchers 
on natural plants in breast cancer medication in Malaysia that 
inhibited cell growth in both in vitro and in vivo anticancer activities. 
However, plants from a good number of families have never been 
investigated phytochemically to reveal their active compound as well 
as their mechanism of action. These include Zingiberaceae, Asteraceae, 
Fabaceae, Loranthaceae, Meliaceae, Moraceae, Amaranthaceae, 
Araceae, Solanaceae, Annonaceae, Acanthaceae, Apocynaceae, 
Liliaceae, Rubiaceae, Apiaceae, Lauraceae, and Piperaceae (in order 
of appearance) which have diverse uses in traditional medicine, 
some of the phytochemicals with potency includes Anonaine, Atisine, 
genistein, glistein, ritun, pymaein, antimycin, aspreuloside, calotoxin, 
calotropin, bauhinoxepin, bauhiniastatins, caratol, and xanthorrhizol, 
and apoptosis and cell proliferation were the major biological pathway 
in cell death [33,37,39,40] in MCF-7 and MDA-231 cell lines. The 
present study calls for further research aimed at isolating the bioactive 
compounds responsible for the observed activity, and also, toxicology 
of these plants also needs to be studied in details and also points out 
their clinical trials. These compounds could serve as novel supports in 
search for new drugs.
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